These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 15986572)
1. Ratios of N-(2,3,4-trihydroxybutyl) valine and N-(2-hydroxy-3-butenyl) valine formed hemoglobin adducts in female mice inhalation exposure with 1,3-butadiene. Lee JH; Kang HS; Han DH Toxicol Ind Health; 2005 Mar; 21(1-2):15-20. PubMed ID: 15986572 [TBL] [Abstract][Full Text] [Related]
2. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism. Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842 [TBL] [Abstract][Full Text] [Related]
3. N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides. Boysen G; Georgieva NI; Upton PB; Walker VE; Swenberg JA Chem Biol Interact; 2007 Mar; 166(1-3):84-92. PubMed ID: 17084829 [TBL] [Abstract][Full Text] [Related]
4. Genotoxicity of 1,3-butadiene and its epoxy intermediates. Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF; Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413 [TBL] [Abstract][Full Text] [Related]
5. Analysis of diepoxide-specific cyclic N-terminal globin adducts in mice and rats after inhalation exposure to 1,3-butadiene. Boysen G; Georgieva NI; Upton PB; Jayaraj K; Li Y; Walker VE; Swenberg JA Cancer Res; 2004 Dec; 64(23):8517-20. PubMed ID: 15574756 [TBL] [Abstract][Full Text] [Related]
6. Dose responses for the formation of hemoglobin adducts and urinary metabolites in rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-(14)C]-butadiene. Booth ED; Kilgour JD; Watson WP Chem Biol Interact; 2004 Mar; 147(2):213-32. PubMed ID: 15013822 [TBL] [Abstract][Full Text] [Related]
8. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene. Koc H; Tretyakova NY; Walker VE; Henderson RF; Swenberg JA Chem Res Toxicol; 1999 Jul; 12(7):566-74. PubMed ID: 10409395 [TBL] [Abstract][Full Text] [Related]
9. Exposure-response of 1,2:3,4-diepoxybutane-specific N-terminal valine adducts in mice and rats after inhalation exposure to 1,3-butadiene. Georgieva NI; Boysen G; Bordeerat N; Walker VE; Swenberg JA Toxicol Sci; 2010 Jun; 115(2):322-9. PubMed ID: 20176624 [TBL] [Abstract][Full Text] [Related]
10. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites. Walker VE; Meng Q Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840 [TBL] [Abstract][Full Text] [Related]
11. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene. Blair IA; Oe T; Kambouris S; Chaudhary AK Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841 [TBL] [Abstract][Full Text] [Related]
13. Hemoglobin adducts of epoxybutene in workers occupationally exposed to 1,3-butadiene. Begemann P; Srám RJ; Neumann HG Arch Toxicol; 2001 Jan; 74(11):680-7. PubMed ID: 11218044 [TBL] [Abstract][Full Text] [Related]
14. Urinary metabolites and haemoglobin adducts as biomarkers of exposure to 1,3-butadiene: a basis for 1,3-butadiene cancer risk assessment. Boogaard PJ; van Sittert NJ; Megens HJ Chem Biol Interact; 2001 Jun; 135-136():695-701. PubMed ID: 11397424 [TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of N-terminal valine peptide adducts specific for 1,2-epoxy-3-butene. Georgieva NI; Boysen G; Upton PB; Jayaraj K; Gold A; Swenberg JA Chem Biol Interact; 2007 Mar; 166(1-3):219-25. PubMed ID: 16860298 [TBL] [Abstract][Full Text] [Related]
16. Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol. Powley MW; Li Y; Upton PB; Walker VE; Swenberg JA Carcinogenesis; 2005 Sep; 26(9):1573-80. PubMed ID: 15888494 [TBL] [Abstract][Full Text] [Related]
17. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach. Motwani HV; Törnqvist M Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046 [TBL] [Abstract][Full Text] [Related]
18. Biomarkers of exposure to 1,3-butadiene as a basis for cancer risk assessment. van Sittert NJ; Megens HJ; Watson WP; Boogaard PJ Toxicol Sci; 2000 Jul; 56(1):189-202. PubMed ID: 10869468 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the disposition of butadiene epoxides in Sprague-Dawley rats and B6C3F1 mice following a single and repeated exposures to 1,3-butadiene via inhalation. Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF Toxicology; 1997 Nov; 123(1-2):125-34. PubMed ID: 9347927 [TBL] [Abstract][Full Text] [Related]